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ABSTRACT 
Objective: To systematically assess the diagnostic utility of MRI to differentiate 
spondyloarthritis (SpA) patients from patients with non-specific back pain (NSBP) and 
healthy volunteers using a standardized evaluation of MR images of the sacroiliac 
joints (SIJ).  
Methods: Five readers blinded to patient and diagnosis independently assessed MRI 
scans (T1-weighted and STIR sequences) of the SIJ from 187 subjects: 75 patients 
with AS (symptom duration ≤10 years); 27 patients with pre-radiographic inflammatory 
back pain (IBP) (mean symptom duration 29 months); 26 NSBP and 59 healthy con-
trols ≤45 years. Bone marrow edema (BME), fat infiltration, erosion, and ankylosis 
were recorded according to standardized definitions using an online data entry sys-
tem. We calculated sensitivity, specificity, positive (LR+) and negative (LR-) likelihood 
ratios for the diagnosis of SpA based on global assessment of the MRI scans.  
Results: Diagnostic utility was high for all 5 readers for both AS (sensitivity 0.90, 
specificity 0.97, LR+ 44.6) and pre-radiographic IBP patients (sensitivity 0.51, speci-
ficity 0.97, LR+ 26.0). Diagnostic utility based solely on detection of BME enhanced 
sensitivity (67%) for IBP patients but reduced specificity (88%); detection of erosions 
in addition to BME further enhanced sensitivity (81%) without changing specificity. A 
single MRI lesion of the SIJ was observed in up to 27% of control individuals.  
Conclusion: This systematic and standardized evaluation of SIJ in SpA patients 
showed that MRI has much greater diagnostic utility than documented previously. We 
present for the first time a data driven definition of a positive MRI for SpA.  
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INTRODUCTION 
Diagnosing early spondyloarthritis (SpA) in young patients presenting with 
symptoms of inflammatory back pain (IBP) and normal findings on plain radiographs 
of the sacroiliac joints (SIJ) remains a challenge in routine practice. Radiography 
detects post-inflammatory structural changes in the subchondral bone of the SIJ but 
these may become evident only after a symptom duration of several years (1, 2). 
Magnetic resonance imaging (MRI) is capable of detecting inflammatory changes in 
bone marrow and soft tissues and is now widely accepted as the most sensitive 
imaging modality for detecting sacroiliitis, the hallmark of SpA. It may therefore detect 
abnormalities in the SIJ prior to radiography. A systematic literature review in 2004 (3) 
addressed those studies that focused on the diagnostic utility of MRI in patients with 
either established ankylosing spondylitis (AS) or IBP and concluded that the overall 
sensitivity and specificity of MRI for SpA was 0.90 with a positive likelihood ratio 
(LR+) of 9.0. This estimate of diagnostic utility has since been incorporated into 
diagnostic algorithms for diagnosing SpA in clinical practice which rely on estimates 
of the degree to which a positive MRI increases the pre-test probability of SpA.  
There are several reasons, however, why this estimate of diagnostic utility 
requires re-appraisal. Most studies included in the systematic review lacked age and 
sex matched controls and used dynamic (not standard) contrast-enhanced MR 
imaging which is costly, unreliable, and not used in routine practice (4-8). Moreover, 
there is increasing acceptance of the necessity for including certain methodological 
aspects of study design such as standardization of technique for acquiring and 
reading MR images, consensus definitions of abnormalities visible on MRI, and 
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standardized calibration/training of readers from different sites. These requirements 
are aimed at ensuring external validity of study conclusions.  
The recently published Assessment of SpondyloArthritis (ASAS) International 
Society classification criteria for axial spondyloarthritis (9) include for the first time a 
positive MRI demonstrating sacroiliitis as an acceptable imaging criterion indicative of 
SpA but require the additional presence of at least one clinical feature of SpA. An 
ASAS working group has also proposed a definition of a positive MRI for sacroiliitis 
according to consensus opinion that is entirely based on the presence of bone 
marrow edema on the short tau inversion recovery (STIR) sequence or osteitis on the 
T1-weighted gadolinium enhanced sequence (T1 post-Gd) (10). Structural 
abnormalities that may be observed on T1-weighted sequences are not included in 
this definition.  
In this report, we describe a multicenter evaluation of the diagnostic utility of 
MRI in patients with SpA that includes age and sex matched controls, uses MR 
sequences widely used in clinical practice, and is based on a standardized 
methodology for the diagnostic evaluation of the SIJ by MRI as follows: 1. 
Implementation of standardized definitions of active inflammatory and structural 
lesions of the SIJ on MRI by the Canada-Denmark MRI Working Group (11, 12); 2. 
Development of a reference SIJ MR image set by consensus amongst study 
investigators based on these definitions (www.arthritisdoctor.ca); 3. Calibration of 
readers using an online training module developed by the Spondyloarthritis Research 
Consortium of Canada (SPARCC) (13; www.arthritisdoctor.ca) followed by 
videoteleconferences; 4. Development of a customized online data entry module 
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based on a standardized approach to recording abnormalities in the SIJ 
(www.arthritisimaging.ca).  
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PATIENTS AND METHODS 
Subjects 
SpA patients: 102 SpA patients aged ≤45 years were recruited in the 
rheumatologic outpatient clinics of 2 university hospitals in Edmonton and Zurich. 75 
patients met the modified New York classification criteria for AS (14) and had a 
disease duration ≤10 years. Nineteen patients with IBP (Balgrist) not fulfilling the 
radiographic modified New York criteria met the Berlin criteria for IBP (15) and 
showed additionally ≥1 clinical or laboratory feature of SpA. Eight patients with IBP 
(Edmonton) not meeting modified New York criteria were defined according to the 
Calin criteria (16) and expert opinion. The 27 IBP patients showed a mean symptom 
duration of 29 months. SpA patients with ongoing or previous treatment with tumor 
necrosis factor alpha-inhibitors were not eligible for this study. Plain pelvic 
radiographs of both SpA patient groups were independently assessed and 
categorized according to the modified New York criteria (14) by two readers at each 
site.  
Control groups: The first control group consisted of 26 patients with non-
specific back pain (NSBP) aged ≤45 years. NSBP patients were defined on clinical 
grounds and according to plain radiographs of the SIJ. A second control group 
consisted of 59 healthy volunteers from the staff of both university hospitals that were 
recruiting the SpA patients. The healthy controls aged ≤45 years were defined by the 
Nordic questionnaire (17); volunteers with symptoms compatible with IBP or clinical 
features suggestive for SpA (such as psoriasis of the skin or chronic inflammatory 
bowel disease) were excluded.  
Page 8 of 44
John Wiley & Sons
Arthritis & Rheumatism
 9 
The study protocol was approved by the local Ethics Committees; the patients 
and the healthy participants all gave written informed consent.  
MRI protocol 
Scans from both centres included coronal T1-weighted Turbo spin-echo 
(T1SE) and STIR sequences angled parallel to the sacroiliac joint. The scan parame-
ters for all sequences were: 15-19 slices, 4 mm slice thickness, 0.4 mm interslice gap 
and field of view of 280-300 mm. For the T1-weighted sequence, repetition time (TR) 
was 423-450 ms, echo time (TE) 12-13 ms, Echo Train Length (ETL) 3, Matrix 
512x256 pixels. For the STIR sequence, the values were: TR 3700-4930 ms, inver-
sion time (TI) 145-150 ms, TE 50-69 ms, ETL 7-9, Matrix 256-384x256 pixels. These 
are the usual sequences and scan parameters for routine MRI evaluation of patients 
with SpA in the involved institutions.  
Standardized assessment of MR images 
STIR and T1-weighted sequences of semicoronal MR scans of the SIJ were 
read and scored independently by 5 readers (2 radiologists: JH, RGL; 3 rheumatolo-
gists: MØ, UW, WPM) blinded to patient demographics and diagnosis. The films were 
evaluated in random order on electronic work stations in the institution of each reader.  
These are the steps that were followed in chronological order.  
1. Standardized definitions of MR lesions: We adopted standardized definitions 
of active inflammatory and structural lesions of the SIJ on MRI developed by the 
Canada-Denmark MRI Working Group (11, 12). We focused on 4 types of MRI le-
sions: Bone marrow edema (BME) on STIR images; joint erosion, marrow fat infiltra-
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tion and ankylosis on T1-weighted images (Figure 1A-1D). Bone sclerosis and ab-
normalities of the synovial cavity were not addressed because of poor reproducibility 
in pre-readout exercises.  
2. Reference SIJ MR image set: We developed a reference SIJ MR image set 
by consensus amongst study investigators based on the definitions for these 4 types 
of lesion (13; www.arthritisdoctor.ca). Four videoteleconference sessions involving 
the 3 university centers focused on the application of the standardized definitions of 
SIJ MRI lesions and served to calibrate the reader team by conducting two test read-
ing exercises on SIJ scans displaying acute and structural inflammatory lesions. The 
reference image set served as a benchmark at the time of reading the study MR im-
ages and included lesions considered to be at the threshold of detection to facilitate 
calibration and the assignment of questionable lesions.  
3. Standardized assessment of MR lesions of the SIJ: We standardized the 
approach to assessing MR images of the SIJ by adopting the methodology outlined in 
the SPARCC online training module (13, 18). This training module has been validated 
by demonstrating that inexperienced rheumatology fellows can achieve reliability of 
detection of BME comparable to that recorded by experienced SPARCC readers after 
reviewing the training module (13). Principal features of the module include the sys-
tematic assessment of the SIJ from anterior to posterior, at least one SIJ must be a 
minimum of 1 cm vertical height in order to score that image, once an SIJ is at least 3 
cm or more in vertical height it is divided at the mid point into four equal upper and 
lower sacral and iliac quadrants. At the posterior aspect of the SIJ there is a natural 
division of the joint into upper and lower quadrants by intervening fat and fibrous tis-
sue.  
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4. Online data entry module: We developed a customized online data entry 
module for recording MRI findings based on a standardized approach to recording 
abnormalities in the SIJ. It has 2 sections. The first section contains 3 questions that 
address global assessment of each scan: 1. “This MRI scan confirms the presence of 
SpA (agree/disagree)”; 2. “Your conclusion is based on which MRI sequence (STIR, 
T1SE, both sequences)”; 3. “What is the primary MRI feature on which your diagnosis 
of SpA is based (bone marrow edema, fat infiltration, bone erosion, ankylosis, not 
applicable as SpA is not present)”. The second section of the web-based data entry 
module consists of a detailed recording section where the SIJ is represented as a 
schematic with 4 quadrants (upper and lower ilium, upper and lower sacrum). Each 
lesion, except for ankylosis, is recorded as being present/absent on a dichotomous 
basis in each quadrant. Ankylosis is recorded in each half of the joint (upper and/or 
lower).  
Statistical analysis 
The distribution of the 4 MRI lesions in patients and controls was analyzed de-
scriptively according to single readers, mean (range) values for all 5 readers, and 
concordant data recorded by at least 2 readers. The ASAS proposed definition of a 
positive MRI based on consensus opinion stipulates the requirement for 2 BME le-
sions on the same slice or if only a single BME lesion is evident it must be present on 
2 consecutive slices (10). We considered this definition as being met in our data entry 
module in two circumstances. The first would be when a score of at least 2 for BME 
was recorded on the same slice indicating 2 BME lesions in 2 distinct SIJ quadrants 
or a single lesion extending across 2 SIJ quadrants. The second circumstance would 
also be a score of at least 2 for BME but this would be due to a score of 1, indicating 
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a single BME lesion, being recorded on 2 consecutive slices in the same SIJ quad-
rant. We adopted a similar approach to descriptive data for erosions and fat infiltra-
tion.  
Diagnostic utility of MRI for SpA according to global evaluation of both T1-
weighted and STIR MR scans was determined by calculating sensitivity, specificity, 
positive (LR+) and negative likelihood ratios (LR-) for individual reader data, concor-
dant data according to at least 2 readers, and for data recorded concordantly by all 3 
rheumatologists and both radiologists. These analyses were repeated for the pro-
posed ASAS definition of a positive MRI. We also formulated a data-driven proposal 
for a positive MRI after recording a high frequency and specificity of erosions in pa-
tients with pre-radiographic SpA and after noting that the diagnostic utility of MRI ac-
cording to the ASAS definition was less than that recorded by global assessment. We 
postulated that global assessment captured additional diagnostic information beyond 
that provided by BME and that this information would largely be due to the presence 
of erosions. We therefore proposed an alternate definition of a positive MRI, termed 
the MORPHO proposal, which defines SpA as being present on MRI if any of the fol-
lowing 3 criteria are met: 1. BME in at least 2 SIJ quadrants in the same slice or a 
single SIJ quadrant in 2 consecutive slices (according to the ASAS definition). 2. Ero-
sion in at least 2 SIJ quadrants in the same slice or a single SIJ quadrant in 2 con-
secutive slices. 3. BME and erosion in any SIJ quadrant though not necessarily in the 
same quadrant. The diagnostic utility of this definition was tested by calculating sensi-
tivity, specificity, LR+ and LR- for individual reader data, concordant data according to 
at least 2 readers, and data recorded by all rheumatologists and both radiologists.  
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RESULTS 
Descriptive analysis 
Demographics of SpA patients and control groups: The mean age of the 75 AS 
patients meeting the modified New York criteria was 31.1 years (standard deviation 
(SD) 6.2) with a mean disease duration of 6.1 years (SD 2.8), 72% were male; the 
mean Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) (19) was 4.4 (SD 
1.9) and the mean Bath Ankylosing Spondylitis Functional Index (BASFI) (20) 2.9 (SD 
2.5), both ranging on a numeric rating scale from 0-10; the mean C-reactive protein 
(CRP) was 10.5 mg/l (SD 18.4). 59 of 71 AS patients who underwent HLA B27 testing 
were positive (83%). The 27 IBP patients (67% male) had a mean age of 29 years 
(SD 6.8) and a mean symptom duration of 29 months (SD 26); their mean BASDAI 
and BASFI were 4.2 (SD 2.1) and 2.6 (SD 2.2), respectively; their mean CRP was 
13.8 mg/l (SD 30.8). 23 of 25 IBP patients tested for HLA B27 were positive (92%).  
59 healthy controls had a mean age of 31.0 years (SD 6.2) and 63% were 
male. The mean age of the 26 NSBP patients was 33.8 years (SD 7.9) with 58% 
being male.  
Frequency of specific MRI abnormalities: The number (percentage) of SpA 
patients and controls with MRI lesions that were recorded concordantly by any 2 
readers and the mean number (range; percentage) for all 5 readers for the 4 
categories of MRI lesions are provided in Table 1. BME, erosion and fat infiltration 
were recorded in both patients and controls while ankylosis was only recorded in SpA 
and NSBP patients. BME was the most common inflammatory lesion in the IBP 
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group, followed by erosion and fat infiltration. In contrast, erosion and fat infiltration 
were recorded more frequently than BME in the AS group. BME meeting the ASAS 
proposal for a positive MRI was recorded concordantly in 67% (18/27) and 85% 
(64/75) of IBP and AS patients, respectively, but it was also recorded concordantly in 
23% of NSBP and 7% of healthy controls. Applying the ASAS operational definition to 
fat infiltration, this was recorded concordantly as being present in at least 2 SIJ 
quadrants on the same slice or in one SIJ quadrant on 2 consecutive slices in 91%, 
37%, 15% and 14% of AS, IBP, NSBP and healthy controls, respectively. Applying 
the ASAS operational definition to erosions, this was recorded concordantly in 91% 
and 48% of AS and IBP patients, respectively, but in only 4% of NSBP and 2% of 
healthy controls.  
Frequency of a diagnosis of SpA in the 4 groups based on the global 
assessment of the SIJ MRI: The number (percentage) of patients diagnosed 
concordantly as SpA by ≥2 readers according to the global evaluation of both MRI 
sequences was 74/75 (99%) for the AS group and 14/27 (52%) for the IBP patients. 
The 13 IBP patients not diagnosed as SpA demonstrated few SIJ quadrants with 
BME, erosion and fat infiltration (11 patients) or no MRI lesions at all (2 patients). One 
AS patient not diagnosed as SpA was reported as having no BME by any reader 
although erosions were recorded in up to 5 SIJ quadrants and fat infiltration in up to 7 
SIJ quadrants. 2/26 (8%) NSBP patients were diagnosed as SpA by 2 readers each, 
primarily on the basis of BME in one patient and both BME and erosions in the 
second patient. A diagnosis of SpA was made in 3/59 (5%) of healthy volunteers (in 1 
control by 3 readers and in 2 controls by 2 readers, respectively). The allocation of 
the 3 healthy volunteers to the SpA group was mainly based on the presence of BME.  
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Concordance and discordance for the diagnosis of SpA according to global 
assessment by MRI: The concordance for the overall assessment between all 5 
readers, the 3 rheumatologists and both radiologists responding to the question “This 
MRI scan confirms the presence of SpA” is shown in Table 2. Concordance was 
defined as all readers of a group being in agreement that the MRI indicated a 
diagnosis of SpA or no SpA. Readers were defined as being discordant for either SpA 
or no SpA depending on whether the majority considered the MRI as indicating SpA 
or no SpA, respectively. This definition for discordance could not be applied to the 
diagnoses reported by the radiologists since there were only two. Concordance for 
the diagnosis of SpA by MRI in the IBP group was 85% for all 5 readers, 89% for the 
3 rheumatologists, and 96% for both radiologists. Concordance for the absence of 
SpA in the 2 control groups was high with 92-96% for the NSBP controls and 93-97% 
for the healthy volunteers.  
Diagnostic utility of MRI for SpA 
1. Diagnostic utility of MRI based on global assessment. Table 3 displays the 
mean (range) sensitivity, specificity, positive and negative LR of all 5 readers for the 
diagnosis of SpA following global assessment of MRI as well as diagnostic assign-
ments recorded concordantly by all 3 rheumatologists, by both radiologists, and by ≥2 
of the 5 readers. Diagnostic utility was, as expected, very high in patients with estab-
lished AS (mean LR+/LR- for all 5 readers = 44.6/0.10). Specificity was consistently 
high amongst all readers (range 94-99%) while sensitivity was somewhat lower for 
rheumatologist readers. Diagnostic utility of MRI for IBP was also high (mean 
LR+/LR- for all 5 readers = 26.0/0.50) with few differences between rheumatologists 
and radiologists.  
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2. Diagnostic utility of MRI based on the ASAS definition of a positive MRI. Ta-
ble 4 compares the diagnostic utility of MRI as determined by global evaluation of all 
scans versus the ASAS definition of a positive MRI. While sensitivity increased for all 
5 readers there was a decrease in specificity when compared to global evaluation of 
MRI. Diagnostic utility of the ASAS definition was therefore less than that determined 
by global assessment for all 5 readers.  
3. Diagnostic utility of MRI based on the MORPHO definition of a positive MRI. 
The inclusion of erosions improved sensitivity (81%) as compared to the ASAS defini-
tion (67%) for all 5 readers with minimal change in specificity so that overall diagnos-
tic utility was better (Table 4). Although the positive LR (6.9) was still not quite as 
good as global assessment of MRI (LR+ = 9.8) the negative LR was better (0.2 ver-
sus 0.5).  
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DISCUSSION 
This international multi-reader MRI standardization, calibration, and reading 
exercise of 187 patients with SpA and age and sex matched controls demonstrated 
several findings that carry major clinical implications for the use of MRI in SpA. First, 
the adoption of a systematic and standardized approach to the assessment of SIJ 
shows that MRI has much greater diagnostic utility than documented previously. Sec-
ond, structural changes occur early in the disease course and are evident in the SIJ 
even in patients with symptom duration of less than 24 months. Third, BME and fat 
infiltration present in more than 1 SIJ quadrant or extending into consecutive slices is 
relatively non-specific and may occur even in healthy, asymptomatic individuals. 
Fourth, erosions are relatively specific for SpA. Fifth, limiting assessment to BME may 
fail to capture significant diagnostic information available from MR sequences ob-
tained during routine screening.  
Our study protocol incorporated several issues relevant to rheumatologic prac-
tice. The inclusion criteria focused on a young population representing the demo-
graphic which develops SpA and also on recent onset SpA patients who may repre-
sent a challenge for early diagnosis. Young NSBP patients and healthy individuals 
constitute essential controls for studies of diagnostic utility in early SpA patients who 
have yet to develop unequivocal radiographic sacroiliitis and therefore reflect a fre-
quent diagnostic challenge in daily practice. MRI protocols using T1-weighted and 
STIR sequences to evaluate SIJ in clinically suspected SpA are widely used in clinical 
practice; two recent studies showed that additional expensive and time consuming 
contrast enhanced MRI sequences do not improve diagnostic utility in this clinical set-
ting over T1-weighted and STIR sequences alone for the evaluation of the SIJ (21) 
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and the spine (22). The importance of calibrating readers from different institutions 
prior to MRI reading exercises has been demonstrated in previous studies evaluating 
the SIJ and the spine in SpA patients (23, 24).  
Concordance amongst all 5 readers for the diagnosis of SpA by global as-
sessment of SIJ MRI was 85% in the IBP group and 68% in the AS group. Similar 
concordance values for the 3 rheumatologists (89% and 78% for the 2 patient groups) 
compared with both radiologists (96% versus 87%) support the external validity of our 
study results. A study evaluating active and structural MRI changes in the SIJ of 68 
patients with recent-onset IBP showed a concordance rate between 2 readers of 78-
85% for acute inflammation and 81%-88% for structural changes (25).  
In the AS group, erosion and fat infiltration in the SIJ as recorded by ≥2 read-
ers were as frequent as BME while BME was observed more frequently than struc-
tural lesions in the IBP group. However, erosions were detected in half of the IBP pa-
tients reporting a mean symptom duration of 29 months; this finding indicates that 
structural damage of the SIJ starts early in the disease course long before it can be 
captured by plain radiography. Also fat infiltration was recorded in up to 44% of the 
IBP population; its specificity for SpA has been a matter of debate since early reports 
on the use of MRI in the diagnostic work-up of SpA patients (26-29). Fat infiltration is 
not necessarily inflammation driven. Further work is needed to assess the diagnostic 
utility of fat infiltration per se or in combination with other MRI lesions suggestive for 
SpA.  
BME and erosions as well as fat infiltration were recorded concordantly by ≥2 
readers in up to 27% of NSBP controls and 24% of healthy volunteers. This observa-
tion is consistent with a previous report describing the occurrence of BME in the SIJ 
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of 27% of mechanical back pain and healthy controls (30) and of 26% of healthy vol-
unteers in a recent study assessing acute spinal lesions by MRI in early SpA (24). 
The pathophysiological basis of these acute and structural MR changes remains 
speculative; the most likely explanations may be mechanically induced signal altera-
tions or degenerative changes. Two NSBP and three healthy controls were diagnosed 
as SpA by some readers according to the global assessment of the MRI scans. Ethi-
cal reasons prevented further examination of these 5 individuals for instance by test-
ing for HLA B27. The clinical implication from these observations is that low grade 
acute lesions of the SIJ visible on MRI should be interpreted with caution to avoid 
misclassification of young subjects with back pain as SpA patients. Compared to 
BME-like lesions and fat infiltration, erosions were observed much less frequently in 
both control groups and they may contribute most to improve specificity.  
A clinically relevant finding of our study was that the specificity obtained by 
global assessment of SIJ MRI, which reflects daily routine, was greater in the IBP 
group than that observed with the more detailed assessment of both the ASAS (10) 
and MORPHO proposals. This may be partly explained by a possible reader’s bias 
when starting the detailed scoring after global assessment of the MRI: once the scan 
is regarded as negative for SpA the reader may be less likely to record inflammatory 
lesions. However, both detailed evaluations showed a higher sensitivity which is de-
sirable in clinical routine to diagnose individual SpA patients early in the disease 
course. The lower negative LR of the MORPHO proposal compared to the other two 
approaches may prove useful in daily routine where ruling out a diagnosis of SpA is 
often as important as confirming the disorder. Incorporating structural lesions in the 
detailed assessment defined by the MORPHO proposal as opposed to the ASAS ap-
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proach based only on BME resulted in a higher sensitivity while maintaining specific-
ity. To our knowledge, the MORPHO proposal represents the first data driven defini-
tion of a positive MRI for SpA. Whether this evaluation system, encompassing both 
active and structural SIJ lesions, is able to enhance diagnostic utility has to be con-
firmed in larger populations of SpA patients, particularly in the preradiographic IBP 
group.  
Limitations of our work are the cross-sectional study design and the relatively 
low number of IBP patients, who represent the most challenging group of SpA pa-
tients in daily routine with a need to confirm the diagnosis suspected on clinical 
grounds. Long-term follow up of the IBP patients will allow estimation of the sensitivity 
and specificity of MRI according to the gold standard of radiographic sacroiliitis. The 
greater sensitivity and hence better diagnostic utility of the radiologists in this study 
was mainly due to the more frequent recognition of structural lesions suggesting that 
rheumatologists may require greater awareness and more intensive training to recog-
nize structural lesions if they are to improve their ability to diagnose SpA on MRI.  
In conclusion, this cross-sectional study adopting a systematic and standard-
ized evaluation of acute and structural lesions of the SIJ showed that MRI has much 
greater diagnostic utility in SpA than documented previously. This study also showed 
that low grade acute and structural SIJ lesions may be present in NSBP patients and 
healthy volunteers with a frequency of up to 27%. Future studies focusing on stan-
dardized evaluation of SIJ lesions should address the contribution of structural SIJ 
damage to diagnostic utility in early SpA. There is a need for greater awareness and 
training of rheumatologists in recognizing structural lesions on SIJ MRI.  
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APPENDIX 
 
The study was called “MORPHO” because the morphological appearance of bright 
bone marrow edema on STIR images involving both sides of each sacroiliac joint re-
sembles the pattern of light reflexion on opened wings of Morpho butterflies (Morpho 
spec.) occurring in South-American rainforests.  
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TABLES 
Table 1 
Frequency of SpA patients and controls with specific MRI abnormalities as recorded 
concordantly by ≥2 readers (percentage) and according to mean (range; percentage) 
for all 5 readers.  
Table 2 
Concordance for the diagnosis of SpA according to global assessment by MRI.  
Table 3 
Diagnostic utility of MRI for SpA as determined by global assessment of MRI by indi-
vidual readers and according to diagnostic assignments recorded concordantly.  
Table 4 
Diagnostic utility of MRI by global assessment of all scans as compared to the ASAS 
and MORPHO definitions of a positive MRI in patients with IBP.  
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FIGURE LEGENDS 
Figure 1A-1D. 4 types of acute and structural MRI lesions of the SIJ.  
Figure 1A. Bone marrow edema (BME; arrows; STIR) in all quadrants of both SIJ. 
BME is defined as an increase in bone marrow signal in the SIJ on STIR images; the 
center of the sacrum at the same craniocaudal level is used as the primary reference 
for normal bone marrow signal. 28 years old HLA B27 positive female IBP patient with 
a symptom duration of 15 months.  
Figure 1B. Erosion at the sacral side of the right SIJ (arrow; T1SE). An erosion is 
defined as a full-thickness loss of dark appearance of either iliac or sacral cortical 
bone of the SIJ and loss of normal bright appearance of adjacent bone marrow on T1-
weighted images; adjacent bone marrow demonstrates decreased signal intensity on 
T1-weighted images as compared to normal iliac or sacral marrow on the same slice 
at the same craniocaudal level. The lower iliac part of the right SIJ shows an erosion 
at threshold of definition (striped arrow) while sclerosis (dotted arrow) is seen in the 
upper iliac half of the right SIJ (2 open arrowheads point to the marrow signal medial 
to the dark area which is similar to adjacent iliac marrow). The left SIJ displays 
sclerosis and definite erosion in the left iliac bone (filled in arrowheads) and, as a 
consequence, pseudo-widening of joint space; loss of adjacent marrow signal is 
visible compared to normal iliac marrow. HLA B27 positive male AS patient aged 25 
years, symptom duration 24 months.  
Figure 1C. Fat infiltration (arrows; T1SE) predominantly on the sacral side of both 
SIJ (arrows). Fat infiltration is defined as a focal increased signal in bone marrow on 
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T1-weighted images. 28 years old HLA B27 positive male AS patient with a symptom 
duration of 7 years.  
Figure 1D. Ankylosis (arrows; T1SE) in the distal part of both SIJ. Ankylosis is 
defined as bright signal on T1-weighted images extending across the SIJ. 42 years 
old HLA B27 negative male AS patient, symptom duration 8 years.  
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Table 1. Frequency of SpA patients and controls with specific MRI abnormalities as recorded concordantly by ≥2 readers (percentage) and according to mean (range; percentage) for all 
5 readers. 
________________________________________________________________________________________________________________________________________________________________ 
Group   Bone marrow edema  Erosion    Fat infiltration   Ankylosis 
   Concordant (%) / Mean (range; %) Concordant (%) / Mean (range; %) Concordant (%) / Mean (range; %) Concordant (%) / Mean (range; %) 
______________________________________________________________________________________________________________________________________________ 
75 AS patients 
≥1 SIJ quadrant  68 (90.7%) / 62.8 (59-68; 83.7%) 70 (93.3%) / 59.4 (42-71; 79.2%) 70 (93.3%) / 65.2 (64-67; 86.9%) 20 (26.7%) / 18.4 (11-27; 24.5%) 
≥2 SIJ quadrants  65 (86.7%) / 60.4 (57-67; 80.5%) 68 (90.7%) / 56.6 (37-68; 75.5%) 68 (90.7%) / 62.2 (61-66; 82.9%) 14 (18.7%) / 14.2 (10-19; 18.9%) 
ASAS proposal*  64 (85.3%) / 59.8 (57-66; 79.7%)* 68 (90.7%) / 56 (37-68; 74.7%)** 68 (90.7%) / 62 (60-66; 82.7%)** NA 
≥3 SIJ quadrants  62 (82.7%) / 58.0 (54-66; 77.3%) 63 (84.0%) / 52.2 (32-68; 69.6%) 66 (88.0%) / 58.8 (55-64; 78.4%) 13 (17.3%) / 12.6 (9-18; 16.8%) 
27 IBP patients 
≥1 SIJ quadrant  21 (77.8%) / 18.6 (16-21; 68.9%) 16 (59.3%) / 13.0 (8-20; 48.1%) 12 (44.4%) / 9.6 (7-12; 35.6%) 0 (0%) / 0.2 (0-1; 0.007%) 
≥2 SIJ quadrants  18 (66.7%) / 16.4 (14-19; 60.7%) 16 (59.3%) / 11.6 (6-19; 43.0%) 10 (37.0%) / 8.6 (6-11; 31.9%) 0 (0%) / 0 (0; 0%) 
ASAS proposal*  18 (66.7%) / 16.2 (14-18; 60.0%)* 13 (48.1%) / 10.4 (5-18; 38.5%)** 10 (37.0%) / 8.4 (6-11; 31.1%)** NA 
≥3 SIJ quadrants  16 (59.3%) / 15.4 (14-17; 57.0%) 11 (40.7%) / 8.2 (4-14; 30.4%) 9 (33.3%) / 7.2 (5-9; 26.7%) 0 (0%) / 0 (0; 0%) 
26 NSBP patients 
≥1 SIJ quadrant  7 (26.9%) / 6.2 (3-12; 23.8%) 2 (7.7%) / 2.8 (0-6; 10.8%)  5 (19.2%) / 4.6 (2-7; 17.7%) 0 (0%) / 0.4 (0-1; 0.02%) 
≥2 SIJ quadrants  6 (23.1%) / 4.4 (2-9; 16.9%) 2 (7.7%) / 1.6 (0-3; 6.2%)  5 (19.2%) / 3.8 (2-6; 14.6%) 0 (0%) / 0.2 (0-1; 0.008%) 
ASAS proposal*  6 (23.1%) / 4.2 (2-8; 16.2%)* 1 (3.8%) / 1.2 (0-2; 4.6%)** 4 (15.4%) / 3.6 (2-6; 13.8%)** NA 
≥3 SIJ quadrants  5 (19.2%) / 3.4 (2-5; 13.1%) 1 (3.8%) / 0.8 (0-2; 3.1%)  2 (7.7%) / 2.4 (2-3; 9.2%)  0 (0%) / 0.2 (0-1; 0.008%) 
59 healthy controls 
≥1 SIJ quadrant  13 (22.0%) / 11 (4-19; 18.6%) 5 (8.5%) / 5.8 (1-13; 9.8%)  14 (23.7%) / 10.2 (6-19; 17.3%) 0 (0%) / 0 (0; 0%) 
≥2 SIJ quadrants  7 (11.9%) / 5.6 (3-12; 9.5%) 2 (3.4%) / 3 (1-10; 5.1%)  9 (15.3%) / 7.2 (4-14; 12.2%) 0 (0%) / 0 (0; 0%) 
ASAS proposal*  4 (6.8%) / 4.6 (2-9; 7.8%)*  1 (1.7%) / 2 (0-7; 3.4%)**  8 (13.6%) / 7.2 (4-14; 12.2%)** NA 
≥3 SIJ quadrants  5 (8.5%) / 3.6 (1-8; 6.1%)  1 (1.7%) / 1 (0-3; 1.7%)  8 (13.6%) / 5.4 (3-11; 9.2%) 0 (0%) / 0 (0; 0%) 
______________________________________________________________________________________________________________________________________________ 
 
SpA:  Spondyloarthritis 
AS:  Ankylosing spondylitis 
IBP:  Inflammatory back pain 
NSBP:  Non-specific back pain 
Concordant: Concordant lesions for ≥2 readers 
* ASAS proposal for a positive MRI (10): ≥2 BME lesions in 2 distinct SIJ quadrants on the same slice OR a ≥1 BME lesion extending across 2 SIJ quadrants OR a ≥1 BME lesion recorded on 2 
consecutive slices in the same SIJ quadrant  
** ASAS operational definition adapted to erosions and fat infiltration (presence of MRI lesions in at least 2 SIJ quadrants in the same slice or in a single SIJ quadrant on 2 consecutive slices)  
NA:  Not applicable; ankylosis was recorded in each half of the joint, not per quadrants  
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Table 2. Concordance for the diagnosis of SpA according to global assessment by MRI. 
__________________________________________________________________________________________________ 
Group    Agreement for SpA    Agreement for no SpA 
Readers   Concordant  Discordant Concordant  Discordant 
__________________________________________________________________________________________________ 
75 AS patients 
All 5 readers  51 (68%)   19 (25%)  0 (0%)   5 (7%) 
All 3 rheumatologists 56 (75%)   13 (17%)  2 (3%)   4 (5%) 
Both radiologists  65 (87%)   10 (13%)  0 (0%)   NA 
27 IBP patients 
All 5 readers  12 (44%)   2 (7%)  11 (41%)   2 (7%) 
All 3 rheumatologists 13 (48%)   0 (0%)  11 (41%)   3 (11%) 
Both radiologists  13 (48%)   1 (4%)  13 (48%)   NA 
26 NSBP patients 
All 5 readers  0 (0%)   0 (0%)  24 (92%)   2 (8%)1 
All 3 rheumatologists 0 (0%)   1 (4%)  24 (92%)   1 (4%) 
Both radiologists  0 (0%)   NA  25 (96%)   1 (4%) 
59 healthy controls 
All 5 readers  0 (0%)   1 (2%)  55 (93%)   3 (5%)2 
All 3 rheumatologists 1 (2%)   1 (2%)  56 (95%)   1 (2%) 
Both radiologists  0 (0%)   NA  57 (97%)   2 (3%) 
__________________________________________________________________________________________________________ 
 
Definition of “Concordant” and “Discordant”:  
Concordant: all readers of a reader group reported that the MRI indicated SpA or no SpA.  
Discordant: readers were defined as being discordant for either SpA or no SpA depending on whether the majority con-
sidered the MRI as indicating SpA or no SpA, respectively;  
NA: this definition for discordance could not be applied to the diagnoses reported by the radiologists since there were 
only two.  
1
 2 NSBP patients were diagnosed as SpA by 2/5 readers each 
2
 1 healthy control was diagnosed as SpA by 3/5 readers; 2 controls by 2/5 readers each 
SpA: Spondyloarthritis 
AS: Ankylosing spondylitis 
IBP: Inflammatory back pain 
NSBP: Non-specific back pain 
NA: Not applicable 
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Table 3. Diagnostic utility of MRI for SpA as determined by global assessment of MRI by individual readers and according to diagnostic assignments recorded concordantly. 
 
______________________________________________________________________________________________________________________________________________ 
Group     Sensitivity  Specificity  Positive LR  Negative LR 
Readers 
______________________________________________________________________________________________________________________________________________ 
AS versus NSBP and HC combined 
Mean (range) of 5 readers   0.90 (0.83-0.97)  0.97 (0.94-0.99)  44.6 (16.3-72.5)  0.10 (0.01-0.18) 
Concordant assignments: 
3 rheumatologists   0.75   0.99   67.9   0.26 
2 radiologists    0.87   1.0   NC   0.13 
≥ any 2 readers    0.99   0.95   18.6   0.01 
AS versus NSBP 
Mean (range) of 5 readers   0.90 (0.83-0.99)  0.97 (0.92-1.0)  NC (12.5-NC)  0.10 (0.01-0.17) 
Concordant assignments: 
3 rheumatologists   0.75   1.0   NC   0.25 
2 radiologists    0.87   1.0   NC   0.13 
≥ any 2 readers    0.99   0.92   12.8   0.01 
AS versus HC 
Mean (range) of 5 readers   0.90 (0.83-0.99)  0.97 (0.95-0.98)  40.3 (18.8-58.0)  0.10 (0.01-0.17) 
Concordant assignments: 
3 rheumatologists   0.75   0.99   53.4   0.26 
2 radiologists    0.87   1.0   NC   0.13 
≥ any 2 readers    0.99   0.96   23.0   0.01 
IBP versus NSBP and HC combined 
Mean (range) of 5 readers   0.51 (0.48-0.52)  0.97 (0.94-0.99)  26.0 (8.8-43.3)  0.50 (0.49-0.53) 
Concordant assignments: 
3 rheumatologists   0.48   0.99   43.6   0.53 
2 radiologists    0.48   1.0   NC   0.52 
≥ any 2 readers    0.52   0.95   9.8   0.51 
IBP versus NSBP 
Mean (range) of 5 readers   0.51 (0.48-0.52)  0.97 (0.92-1.0)  NC (6.7-NC)  0.50 (0.48-0.54) 
Concordant assignments: 
3 rheumatologists   0.48   1.0   NC   0.52 
2 radiologists    0.48   1.0   NC   0.52 
≥ any 2 readers    0.52   0.92   6.7   0.52 
IBP versus HC 
Mean (range) of 5 readers   0.51 (0.48-0.52)  0.97 (0.95-0.98)  23.0 (10.2-30.5)  0.50 (0.49-0.53) 
Concordant assignments: 
3 rheumatologists   0.48   0.99   34.3   0.53 
2 radiologists    0.48   1.0   NC   0.52 
≥ any 2 readers    0.52   0.96   12.1   0.50 
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______________________________________________________________________________________________________________________________________________ 
 
LR: Likelihood ratio 
SpA: Spondyloarthritis 
AS: Ankylosing spondylitis 
IBP: Inflammatory back pain 
NSBP: Non-specific back pain 
HC: Healthy control 
NC: Not calculable (specificity = 1.0) 
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Table 4. Diagnostic utility of MRI by global assessment of all scans as compared to the ASAS and MORPHO definitions of a positive MRI 
in patients with IBP.  
____________________________________________________________________________________________________________________ 
Diagnosis by overall assessment  Diagnosis by ASAS proposal  Diagnosis by MORPHO proposal 
____________________________________________________________________________________________________________________ 
Reader Sens Spec LR+ LR- Sens Spec LR+ LR- Sens Spec LR+ LR- 
____________________________________________________________________________________________________________________ 
R1 0.48 0.98 20 0.5 0.52 0.93 7.3 0.5 0.74 0.86 5.3 0.3 
R2 0.52 0.97 14.8 0.5 0.59 0.92 7.3 0.4 0.63 0.91 7.0 0.3 
R3 0.52 0.94 8.8 0.5 0.67 0.85 4.5 0.4 0.78 0.85 5.2 0.3 
R4 0.52 0.99 43.3 0.5 0.56 0.94 8.8 0.5 0.70 0.92 8.8 0.3 
R5 0.52 0.99 43.3 0.5 0.67 0.89 6.0 0.4 0.74 0.89 6.7 0.3 
Any 2 R 0.52 0.95 9.8 0.5 0.67 0.88 5.7 0.4 0.81 0.88 6.9 0.2 
____________________________________________________________________________________________________________________ 
 
Sens: Sensitivity 
Spec: Specificity 
LR+: Positive likelihood ratio 
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LR-: Negative likelihood ratio 
R: Reader 
ASAS proposal for a positive MRI (10): ≥2 BME lesions in 2 distinct SIJ quadrants on the same slice OR a ≥1 BME lesion extending across 2 SIJ 
quadrants OR a ≥1 BME lesion recorded on 2 consecutive slices in the same SIJ quadrant. 
MORPHO proposal for a positive MRI: Any of the following 3 criteria are met: 1. BME according to the ASAS definition. 2. Erosion in ≥ 2 SIJ 
quadrants in the same slice or a single SIJ quadrant in 2 consecutive slices. 3. BME and erosion in any SIJ quadrant though not necessarily in the 
same quadrant. 
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HORIZONTAL FIGURE TEMPLATE FOR A&R 
 
Figure 1A-1D. 4 types of acute and structural MRI lesions of the SIJ. 1A. Bone marrow edema (BME; arrows; STIR) in all quadrants of both SIJ. 
BME is defined as an increase in bone marrow signal in the SIJ on STIR images; the center of the sacrum at the same craniocaudal level is used 
as the primary reference for normal bone marrow signal. 28 years old HLA B27 positive female IBP patient with a symptom duration of 15 
months. 1B. Erosion at the sacral side of the right SIJ (arrow; T1SE). An erosion is defined as a full-thickness loss of dark appearance of either 
iliac or sacral cortical bone of the SIJ and loss of normal bright appearance of adjacent bone marrow on T1-weighted images; adjacent bone 
marrow demonstrates decreased signal intensity on T1-weighted images as compared to normal iliac or sacral marrow on the same slice at the 
same craniocaudal level. The lower iliac part of the right SIJ shows an erosion at threshold of definition (striped arrow) while sclerosis (dotted 
arrow) is seen in the upper iliac half of the right SIJ (2 open arrowheads point to the marrow signal medial to the dark area which is similar to 
adjacent iliac marrow). The left SIJ displays sclerosis and definite erosion in the left iliac bone (filled in arrowheads) and, as a consequence, 
pseudo-widening of joint space; loss of adjacent marrow signal is visible compared to normal iliac marrow. HLA B27 positive male AS patient 
aged 25 years, symptom duration 24 months. 1C. Fat infiltration (arrows; T1SE) predominantly on the sacral side of both SIJ (arrows). Fat 
infiltration is defined as a focal increased signal in bone marrow on T1-weighted images. 28 years old HLA B27 positive male AS patient with a 
symptom duration of 7 years. 1D. Ankylosis (arrows; T1SE) in the distal part of both SIJ. Ankylosis is defined as bright signal on T1-weighted 
images extending across the SIJ. 42 years old HLA B27 negative male AS patient, symptom duration 8 years.  
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Figure 1A. Bone marrow edema (BME; arrows; STIR image) in all quadrants of both SIJ. BME is 
defined as an increase in bone marrow signal in the SIJ on STIR images; the center of the sacrum 
at the same craniocaudal level is used as the primary reference for normal bone marrow signal. 28 
years old HLA B27 positive female IBP patient with a symptom duration of 15 months.  
139x85mm (300 x 300 DPI)  
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Figure 1B. Erosion at the sacral side of the right SIJ (arrow; T1SE image). An erosion is defined as a 
full-thickness loss of dark appearance of either iliac or sacral cortical bone of the SIJ and loss of 
normal bright appearance of adjacent bone marrow on T1-weighted images; adjacent bone marrow 
demonstrates decreased signal intensity on T1-weighted images as compared to normal iliac or 
sacral marrow on the same slice at the same craniocaudal level. The lower iliac part of the right SIJ 
shows an erosion at threshold of definition (striped arrow) while sclerosis (dotted arrow) is seen in 
the upper iliac half of the right SIJ (2 open arrowheads point to the marrow signal medial to the 
dark area which is similar to adjacent iliac marrow). The left SIJ displays sclerosis and definite 
erosion in the left iliac bone (filled in arrowheads) and, as a consequence, pseudowidening of joint 
space; loss of adjacent marrow signal is visible compared to normal iliac marrow. HLA B27 positive 
male AS patient aged 25 years, symptom duration 24 months.  
139x85mm (300 x 300 DPI)  
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Figure 1C. Fat infiltration (arrows; T1SE image) predominantly on the sacral side of both SIJ 
(arrows). Fat infiltration is defined as a focal increased signal in bone marrow on T1-weighted 
images. 28 years old HLA B27 positive male AS patient with a symptom duration of 7 years.  
139x85mm (300 x 300 DPI)  
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Figure 1D. Ankylosis (arrows; T1SE image) in the distal part of both SIJ. Ankylosis is defined as 
bright signal on T1-weighted images extending across the SIJ. 42 years old HLA B27 negative male 
AS patient, symptom duration 8 years.  
139x85mm (300 x 300 DPI)  
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